Meridian Bioscience Inc (VIVO) - Financial and Strategic SWOT Analysis Review

Meridian Bioscience Inc (VIVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Meridian Bioscience Inc (Meridian) is a fully integrated life science company that develops, manufactures and distributes diagnostic test kits for viral, gastrointestinal, respiratory and parasitic infectious disease indications. It also manufactures bulk antigens, antibodies, purified reagents, nucleotides and related products for use in research and diagnostic manufacturing. The company develops proteins and other biological materials for use in biotechnology research for new drugs and vaccines. Meridian offers its products to acute care hospitals, outpatient clinics, reference laboratories and physician office laboratories in several countries worldwide. The company has presence in the US, Europe, Africa and the Middle East through direct offices and subsidiaries. Meridian is headquartered in Cincinnati, Ohio, the US.

Meridian Bioscience Inc Key Recent Developments

Jan 07,2019: Meridian Bioscience announces preliminary first quarter 2019 revenue; first quarter 2019 financial results Conference Call
Nov 08,2018: Meridian Bioscience reports fourth quarter and full-year operating results, sets fiscal 2019 cash dividend rate, and provides fiscal 2019 guidance
Nov 08,2018: Meridian Bioscience reports fourth quarter and full-year operating results, sets fiscal 2019 cash dividend rate, and provides fiscal 2019 guidance
Oct 09,2018: DiaSorin and Meridian Enter Into a Strategic Collaboration to Sell Helicobacter Pylori Stool Antigen Test in the United States and in the United Kingdom
Sep 24,2018: Meridian Bioscience announces retirement of John A. Kraeutler, executive chairman of the board; appoints David C. Phillips as chairman of the board; and elects Felicia Williams to the board of directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
 

List of Tables 5
List of Figures 5
Section 1 - About the Company 6
Meridian Bioscience Inc - Key Facts 6
Meridian Bioscience Inc - Key Employees 7
Meridian Bioscience Inc - Key Employee Biographies 8
Meridian Bioscience Inc - Major Products and Services 9
Meridian Bioscience Inc - History 13
Meridian Bioscience Inc - Company Statement 17
Meridian Bioscience Inc - Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Section 2 – Company Analysis 21
Company Overview 21
Meridian Bioscience Inc - Business Description 22
Business Segment: Diagnostics 22
Overview 22
Performance 22
Business Segment: Life Science 22
Overview 22
Performance 22
Geographical Segment: Americas 22
Performance 22
Geographical Segment: EMEA 23
Performance 23
Geographical Segment: ROW 23
Performance 23
R&D Overview 23
Meridian Bioscience Inc - SWOT Analysis 24
SWOT Analysis - Overview 24
Meridian Bioscience Inc - Strengths 24
Meridian Bioscience Inc - Weaknesses 25
Meridian Bioscience Inc - Opportunities 26
Meridian Bioscience Inc - Threats 27
Meridian Bioscience Inc - Key Competitors 28
Section 3 – Company Financial Ratios 29
Financial Ratios - Capital Market Ratios 29
Financial Ratios - Annual Ratios 30
Performance Chart 33
Financial Performance 33
Financial Ratios - Ratio Charts 34
Section 4 – Company’s Lifesciences Financial Deals and Alliances 35
Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019 35
Meridian Bioscience Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019 36
Meridian Bioscience Inc, Recent Deals Summary 37
Section 5 – Company’s Recent Developments 38
Jan 07, 2019: Meridian Bioscience announces preliminary first quarter 2019 revenue; first quarter 2019 financial results Conference Call 38
Nov 08, 2018: Meridian Bioscience reports fourth quarter and full-year operating results, sets fiscal 2019 cash dividend rate, and provides fiscal 2019 guidance 39
Sep 24, 2018: Meridian Bioscience announces retirement of John A. Kraeutler, executive chairman of the board; appoints David C. Phillips as chairman of the board; and elects Felicia Williams to the board of directors 41
Jul 31, 2018: Meridian Bioscience reports third quarter 2018 operating results, declares regular third quarter cash dividend, and reaffirms fiscal 2018 guidance 42
Jul 27, 2018: Dynex Technologies announces global partnership with ZEUS Scientific 44
Apr 26, 2018: Meridian Bioscience Reports Second Quarter 2018 Operating Results, Declares Regular Second Quarter Cash Dividend, and Updates Fiscal 2018 Guidance 45
Mar 22, 2018: Statement from FDAs Donald St. Pierre on findings from ongoing investigation into lead testing issues 47
Mar 21, 2018: Meridian Bioscience Realigns Organizational Structure 48
Jan 25, 2018: Meridian Bioscience Reports Net Revenue Of $52.3 Million In Q1 fiscal 2018 49
Section 6 – Appendix 52
Methodology 52
Ratio Definitions 52
About GlobalData 56
Contact Us 56
Disclaimer 56
 


List Of Tables

Meridian Bioscience Inc, Key Facts 6
Meridian Bioscience Inc, Key Employees 7
Meridian Bioscience Inc, Key Employee Biographies 8
Meridian Bioscience Inc, Major Products and Services 9
Meridian Bioscience Inc, History 13
Meridian Bioscience Inc, Subsidiaries 19
Meridian Bioscience Inc, Key Competitors 28
Meridian Bioscience Inc, Ratios based on current share price 29
Meridian Bioscience Inc, Annual Ratios 30
Meridian Bioscience Inc, Annual Ratios (Cont...1) 31
Meridian Bioscience Inc, Annual Ratios (Cont...2) 32
Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019 35
Meridian Bioscience Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019 36
Meridian Bioscience Inc, Recent Deals Summary 37
Currency Codes 52
Capital Market Ratios 52
Equity Ratios 53
Profitability Ratios 53
Cost Ratios 54
Liquidity Ratios 54
Leverage Ratios 55
Efficiency Ratios 55
 


List Of Figures

Meridian Bioscience Inc, Performance Chart (2014 - 2018) 33
Meridian Bioscience Inc, Ratio Charts 34
Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019 35
Meridian Bioscience Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019 36
 


Meridian Bioscience Inc (VIVO) - Product Pipeline Analysis, 2019 Update

Meridian Bioscience Inc (Meridian) is a fully integrated life science company that develops, manufactures and distributes diagnostic test kits for viral, gastrointestinal, respiratory and parasitic infectious disease indications. It also

USD 750 View Report

Meridian Bioscience Inc (VIVO) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Meridian Bioscience Inc (Meridian) is a fully integrated life science company that carries out the development, manufacturing and distribution of diagnostic test kits for viral, gastrointestinal, respiratory and parasitic infectious

USD 250 View Report

Tosoh Bioscience Inc - Product Pipeline Analysis, 2019 Update

Tosoh Bioscience Inc (TBI), a subsidiary of Tosoh Corp, is a medical device company that offers diagnostic systems. The company provides analyzers, assays, immunoassay solutions, reagent technology, HbA1c solutions, -thalassemia

USD 750 View Report

Meridian Bioscience Inc (VIVO) - Product Pipeline Analysis, 2019 Update

Meridian Bioscience Inc (Meridian) is a fully integrated life science company that develops, manufactures and distributes diagnostic test kits for viral, gastrointestinal, respiratory and parasitic infectious disease indications. It also

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available